Androgel Lawsuit Guide
Men who received testosterone replacement therapy such as AndroGel, Fortesta, Androderm and Striant are filling a lawsuit after they experinced strokes, blood clots and heart attacks. Testosterone medication therapy is used to treat chronic fatigue, depression and erectile dysfunction. Pharmaceutical companies unscrupulously marketed these drugs through misleading advertisement tactics regardless if the male paitent needed it or not.
If you or a member of your family suffered a cardiovascular issue or any other serious side effect after taking any TRT medication, our lawyers could help you seek proper compensation in court. Call our toll-free phone number or fill our form now to speak with an attorney and receive a free legal consultation.
*Please seek the advice of a medical professional before discontinuing the use of this drug.
Medication Type: Testosterone Therapy
Injury: Blood cloths, stroke, and heart attack, death.
Manufacturer: Bayer and Janssen Pharmaceuticals (Johnson & Johnson)
Total Cases: 1,000
Settlement Amounts: EST – $100,000 over $1,000,000
Bellwether Trial Start Date: April 2017
See If You Qualify
what is Androgel
Testosterone Replacement Therapy (TRT) is a hormone therapy used to treat men with unnatural levels of this androgen, a condition known as “low testosterone” or Low-T. Symptoms of this conditions include a subjective feeling of tiredness, chronic fatigue, lack of energy, reduced libido which may lead to erectile dysfunction, as well as many other unwanted physical or psychological changes such as decreased body hair, fragile bones and depression. However, in most instances, no medical condition is causing these symptoms other than just aging or stress, and a TRT is thus seldom appropriate.
The dangerous side effects associated with inappropriate anabolic steroid supplementation have been largely investigated in medicine. The chance of heart attacks and strokes is increased by 30 percent according to a research published in The Journal of the American Medical Association (JAMA). Our lawyers argue the drug may also increase the risk of blood clots since it thickens the blood.
Misleading advertisement and aggressive marketing
In 2006, two whistleblower managers decided to sue AbbVie (formerly Solvay) and provided insider information about how the company allegedly violated the False Claims Act by paying kickbacks to health care providers to aggressively market AndroGel for off-label uses. The medication’s sales ads contained misleading information that presented it as a treatment of “Age-associated hypogonadal causes,” suggesting how men over 65 had lower testosterone levels than men aged 30-35.
Androgen-based drugs, however, were only approved by FDA for use in men who have Low-T levels in conjunction with an associated medical condition, and aging cannot be, by any means, defined as a medical condition. Solvay earned more than $300 million with AndroGel sales in 2006 by touting that five million men in the United States suffered from hypogonadism, without any scientific research to back up this claim.
Why Our Lawyers are filing Low-T lawsuits
All patients who suffered an injury after receiving an inappropriate TRT prescription such as androgel could be eligible for compensation and should file a lawsuit. According to recent court claims, the manufacturers of these products failed to warn the public of the dangers of testosterone pills (Striant), gels (AndroGel, Testim, Fortesta and Axiron), patches (Androderm), injections (Depo-Testosterone and Delatestryl), and implants (Testopel). Victim’s attorneys allege that defendants misrepresented those medicines as safe and effective for age-related Low-T levels despite a serious risk of life-threatening adverse reactions including thromboembolic events and heart attacks.
The pharmaceutical companies deliberately ignored those potential risks in their aggressive advertising campaign in order to convince young and old men to take anabolic steroids even when they were not recommended. Some of the biggest players among the Big Pharma even paid millions of dollars to fund physician education that promoted the extended use of androgen-based medications in off-label conditions such as diabetes, osteoporosis, depression, sexual dysfunction and even HIV and obesity.
To date, more than 1,000 testosterone lawsuit cases have been centralized in the AndroGel Products Liability Litigation MDL No. 2545 in the U.S. District Court for the Northern District of Illinois, overseen by Judge Matthew F. Kennelly. The Multidistrict Litigation consolidated all those actions currently pending against Abbott, AbbVie, Pfizer, Lily, GSK, Auxilium Labs and many others.
the Meds Lawsuit Group, made it simple and easy to file for the medical damages their attorneys really care about getting to know who you are and your injury.
Passionate About Clients Erin Wu 5